November 29, 2016 - By Michael Collier
Advisory Board Co’s Chief Product Officer, Cormac Miller, sold 750 shares of stock in the firm. The approx. average share price was $36.7, for aggregate sale value of $27,525 US Dollars. In the last month, he also unloaded 750 shares that are worth approx $25,973 USD. A Form 4 freely obtainable here discloses this insider activity, that was made on 29-11-2016 and was filed with the U.S. Security and Exchange Commission. Now, he has ownership of 20,986 shares or 0.05% of the company’s total market cap.
Out of 14 analysts covering Advisory Board (NASDAQ:ABCO), 9 rate it a “Buy”, 1 “Sell”, while 4 “Hold”. This means 64% are positive. $65 is the highest target while $40 is the lowest. The $53.60 average target is 47.46% above today’s ($36.35) stock price. Advisory Board has been the topic of 19 analyst reports since August 5, 2015 according to StockzIntelligence Inc. Raymond James downgraded The Advisory Board Company (NASDAQ:ABCO) on Tuesday, July 19 to “Market Perform” rating. The rating was maintained by Barclays Capital on Wednesday, August 5 with “Overweight”. Canaccord Genuity maintained the shares of ABCO in a report on Wednesday, August 5 with “Buy” rating. The firm has “Buy” rating given on Thursday, February 25 by Deutsche Bank. The firm earned “Outperform” rating on Wednesday, August 5 by Oppenheimer. Robert W. Baird upgraded the stock to “Outperform” rating in Monday, August 17 report. The company was maintained on Wednesday, November 2 by Stifel Nicolaus. Credit Suisse initiated the stock with “Outperform” rating in Monday, June 20 report. Cantor Fitzgerald initiated the shares of ABCO in a report on Tuesday, November 10 with “Buy” rating. The firm earned “Sector Weight” rating on Monday, April 18 by KeyBanc Capital Markets.
Insitutional Activity: The institutional sentiment increased to 1.26 in Q2 2016. Its up 0.32, from 0.94 in 2016Q1. The ratio increased, as 25 funds sold all The Advisory Board Company shares owned while 53 reduced positions. 28 funds bought stakes while 45 increased positions. They now own 39.77 million shares or 7.82% less from 43.15 million shares in 2016Q1.
The United Kingdom-based Barclays Pcl has invested 0% in The Advisory Board Company (NASDAQ:ABCO). Sit owns 27,975 shares or 0.03% of their US portfolio. Franklin last reported 0.02% of its portfolio in the stock. Paradigm Asset Mgmt accumulated 0% or 3,100 shares. Moreover, Deutsche State Bank Ag has 0% invested in The Advisory Board Company (NASDAQ:ABCO) for 121,400 shares. Fmr Ltd Liability holds 622,874 shares or 0% of its portfolio. Polar Asset Management Prns Incorporated last reported 0.52% of its portfolio in the stock. Winslow Evans Crocker Incorporated last reported 114 shares in the company. Blackrock Investment Mgmt Ltd Liability Com has 154,200 shares for 0.01% of their US portfolio. The Massachusetts-based Ngam Advsr L P has invested 0.01% in The Advisory Board Company (NASDAQ:ABCO). Legal And General Public Limited has 0% invested in the company for 11,492 shares. Meeder Asset Management accumulated 0% or 935 shares. Rail reported 118,314 shares or 1% of all its holdings. Diam Company Limited last reported 0.05% of its portfolio in the stock. Champlain Invest Ptnrs Lc reported 6,950 shares or 0% of all its holdings.
Insider Transactions: Since May 31, 2016, the stock had 0 buys, and 16 sales for $1.69 million net activity. GRUA PETER J sold $103,600 worth of stock. The insider Musslewhite Robert W sold 5,500 shares worth $180,840. 1,500 shares were sold by Miller Cormac F, worth $64,560 on Wednesday, September 14. Shares for $102,720 were sold by Kirshbaum Michael T. 5,000 shares were bought by KINDICK KELT, worth $164,050. Farber Evan R also sold $119,738 worth of The Advisory Board Company (NASDAQ:ABCO) on Wednesday, August 17. ZUMWALT LEANNE M sold $114,091 worth of The Advisory Board Company (NASDAQ:ABCO) on Monday, August 1.
About 27,888 shares traded hands. The Advisory Board Company (NASDAQ:ABCO) has risen 17.02% since April 26, 2016 and is uptrending. It has outperformed by 11.76% the S&P500.
The Advisory Board Company is a provider of software and solutions to the healthcare and higher education industries. The company has a market cap of $1.45 billion. The Company’s healthcare programs address a range of clinical and business issues, including physician alignment and engagement, network management and growth strategy, value care and population health, revenue cycle, clinical activities and supply chain. It currently has negative earnings. The Company’s higher education programs support colleges and universities in enrollment management; academic programming and student learning; faculty recruitment and retention; student advising and success; alumni affairs and advancement, and college and university operations.
According to Zacks Investment Research, “The Advisory Board Company provides best practices research and analysis to the health care industry, focusing on business strategy, operations and general management issues. The Company provides its best practices research and analysis through discrete annual programs to a membership of more than 2,000 hospitals, health systems, pharmaceutical and biotech companies, health care insurers, and medical device companies in the United States. Each program provides members with best practices research reports, executive education and other supporting research services.”
Analysts await The Advisory Board Company (NASDAQ:ABCO) to report earnings on February, 28. They expect $0.47 earnings per share, up 34.29% or $0.12 from last year’s $0.35 per share. ABCO’s profit will be $18.75 million for 19.34 P/E if the $0.47 EPS becomes a reality. After $0.15 actual earnings per share reported by The Advisory Board Company for the previous quarter, Wall Street now forecasts 213.33% EPS growth.
More notable recent The Advisory Board Company (NASDAQ:ABCO) news were published by: Prnewswire.com which released: “The Advisory Board Company to Participate in the Piper Jaffray Healthcare ..” on November 22, 2016, also Prnewswire.com with their article: “The Advisory Board Company Reports Third Quarter Results” published on November 01, 2016, Prnewswire.com published: “The Advisory Board Company Reports Results For Quarter Ended June 30, 2016” on July 27, 2016. More interesting news about The Advisory Board Company (NASDAQ:ABCO) were released by: Prnewswire.com and their article: “The Advisory Board Company to Report Third Quarter Financial Results After ..” published on October 11, 2016 as well as Globenewswire.com‘s news article titled: “The Advisory Board Company (Nasdaq: ABCO) to Ring The Nasdaq Stock Market ..” with publication date: November 17, 2016.
The Advisory Board Company, incorporated on August 9, 2001, is a well-known provider of software and solutions to the healthcare and higher education industries. The Company’s healthcare programs address a range of clinical and business issues, including physician alignment and engagement, network management and growth strategy, value care and population health, revenue cycle performance, clinical activities and supply chain management. The Company’s education programs support colleges and universities in enrollment management; academic programming and student learning; faculty recruitment and retention; student advising and success; alumni affairs and advancement, and college and university operations. The Firm offers distinct membership programs, across four areas, which include best practices research and insight, performance technology software, consulting and management services, and data- and tech-enabled services.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.